Group items tagged

ProviNET is here to help you achieve improved EMR reporting through custom assessment care plan triggers, automatic notifications, and custom system healthcare integration.

OSP Develops customized AI in Auditing Solutions that provide centralized real-time auditing analysis, advanced reporting, risk adjustment auditing, and productive audit delivery.

The global molecular modelling market is segmented based on the basis of product, application, end-user, and region. The global molecular modelling market was valued at USD 377 million in 2017 and is expected to register a CAGR of 15.46% from 2018 to 2023.

Global Advanced Wound Care and Closure Market is expected to garner $20.5 billion by 2020, registering a CAGR of 8.0% during the forecast period 2014 - 2020. Smith and Nephew, Kinetic Concepts, 3M, BSN medical, Covidien, ConvaTech, Derma Sciences, Integra LifeSciences, Baxter International and Coloplast are some of the major players in the global advanced wound care and closure market. The global advanced wound care and closure market has been segmented based on type, application, end users and geography. Based on type, the global market is segmented into advanced wound closure market and advanced wound care market.

The market for varicose vein treatment is highly fragmented; the increasing prevalence of varicose veins and growing geriatric population are among the primary factors driving the market growth. However, the high cost of treatment procedure and lack of skilled professionals are hampering the growth of the market. The treatment cost for varicose veins is high and the reimbursement scenario is very inconsistent. In 2018, 3 out of 10 individuals were affected by varicose veins with health expenses being more than $10 billion. These costs have increased annually due to a sedentary lifestyle, growing elderly population, and the prevalence of obesity.

The global dialysis market is expected to grow at a steady rate, indicating a CAGR of 5.0% during the forecast period 2019-2025. This is one of the most serviced market in the healthcare industry. The factors that drive the growth of this market include increasing incidence of ESRD diseases, along with a rise in chronic diseases such as diabetes and hypertension. The surge in funding by government and private sectors for dialysis has helped the market witness steady growth. In addition, the increased disposable income also acts as a growth driver. However, the high embedded costs and related challenges in the dialysis industry, along with lack of kidney donors and reduction in reimbursement is expected to dampen the growth of this market.

the "Global Lung Cancer Drugs Market" will grow at a CAGR of 13.6% during the forecast period. The market has witnessed steady growth in the past few years with the introduction of novel products, which have augmented the acceptance of immunotherapy drugs in the market. The market is fueled by upsurge in the incidence of lung cancer cases across the globe - owing to increasing diagnosis rate and mainly due to increasing tobacco consumption, increase in the lung cancer treatment rates, increasing rate of effective drug approvals as first-line therapies, strategic deals to develop new products, increasing R&D spending, and rapid industrialization leading to increased pollution. The report provides complete details about the sub-segments of the lung cancer drugs market. Through this report, the key stakeholders can know about the major trends, drivers, investments, vertical player's initiatives, and government initiatives towards the disease management in the upcoming years along with details of the existing pureplay companies and new players entering the market.

Infoholic's market research report predicts that the global leukemia therapeutics market will grow at a CAGR of 6.2% during the forecast period 2019-2025. Leukemia refers to the group of blood cancer that usually develops in the bone marrow, resulting in the formation of abnormal blood cells. Leukemia is subdivided into lymphoblastic or lymphocytic leukemias and myeloid or myelogenous leukemias that include acute myeloid leukemia (AML), acute lymphocytic leukemia (ALL), chronic lymphocytic leukemia (CLL), and chronic myeloid leukemia (CML). The report provides complete details about the sub-segment of the global leukemia therapeutics market. Moreover, the report provides details about the major challenges that are going to impact the market growth. Additionally, the report gives complete details about the key business opportunities to key stakeholders in order to expand their business and capture the revenue in specific verticals, and to analyze before investing or expanding the business in this market.

The Global Trauma Products Industry was estimated at $6.61 billion in 2018 and is expected to reach $10.41 billion by 2026, growing at a CAGR of 5.8% from 2019 to 2026.

Discover how automation streamlines testing requests and report management in healthcare, optimizing efficiency and enhancing patient care.

The Asia-Pacific oncology molecular diagnostics market was valued at $381.84 million in 2018 and is estimated to reach $732 million by 2026 growing at a CAGR of 9% for the forecast period of 2019-2026. Molecular diagnosis is a method used to identify a disease at the molecular level, such as proteins, DNA, and RNA, in a tissue or fluid. Various tools are used to detect specific sequences of DNA or RNA that may or may not be associated with the disease such as single nucleotide polymorphism (SNP), deletions, rearrangements, and insertions, which are used for diagnosis and prediction of various infectious diseases, cancer, and other genetic disorders.